Home › Funds › CAPTRUST FINANCIAL ADVISORS › GILD

CAPTRUST FINANCIAL ADVISORS position in GILD

GILEAD SCIENCES INC · Health Care

CAPTRUST FINANCIAL ADVISORS reported holding 1,598,202 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$238.2M, representing 0.42% of its reported portfolio and ranking #43 among its reported holdings. CAPTRUST FINANCIAL ADVISORS has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.60M sh
Reported value held$238.21M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPTRUST FINANCIAL ADVISORS's GILD position evolved

CAPTRUST FINANCIAL ADVISORS first disclosed a stake in GILD in Q3 2023 at 1,462,200 shares (US$109.6M). The position peaked in Q1 2026 at 1,771,496 shares, worth US$246.9M. Across 13 filings, CAPTRUST FINANCIAL ADVISORS increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,598,202 shares valued at US$238.2M — a reduction of -165,323 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.46M $109.58M New
Q4 2023 1.49M $120.79M Add
Q1 2024 1.65M $108.81M Add
Q2 2024 1.63M $111.90M Reduce
Q3 2024 1.68M $140.91M Add
Q4 2024 1.78M $164.14M Add
Q1 2025 1.83M $204.72M Add
Q2 2025 1.88M $208.28M Add
Q3 2025 1.91M $211.80M Add
Q4 2025 1.94M $237.64M Add
Q1 2026 1.77M $246.88M Reduce
Q2 2026 1.76M $222.80M Hold
Q3 2026 1.60M $238.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has CAPTRUST FINANCIAL ADVISORS held GILD?

CAPTRUST FINANCIAL ADVISORS has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPTRUST FINANCIAL ADVISORS's current position in GILD?

As of Q3 2026, CAPTRUST FINANCIAL ADVISORS holds 1.60M shares of GILD (GILEAD SCIENCES INC), valued at $238.21M, representing 0.42% of its reported portfolio and ranking #43.

Has CAPTRUST FINANCIAL ADVISORS been buying or selling GILD?

In the latest 13F filing (Q3 2026), CAPTRUST FINANCIAL ADVISORS reduced its position in GILD. The position peaked in Q1 2026 at 1.77M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.